By Lea Gigon | Project Leader
Certain gut bacteria can strengthen the immune system and, in experimental settings, slow tumor growth. The gut is a remarkably complex ecosystem composed of bacteria, fungi, and human cells. What particularly fascinates Prof. Michael Scharl from the Department of Gastroenterology and Hepatology at University Hospital Zurich is the close connection between the gut and the immune system. “I am fascinated by how this micro-world functions and the crucial role it plays in our health,” says the gastroenterologist.
Previous studies had already shown that the composition of the gut microbiome can influence the effectiveness of immunotherapies. In earlier work, Scharl’s team identified specific bacteria—particularly members of the Clostridiales order—that activate immune responses and slow tumor growth in experimental models. Evidence from studies on fecal microbiota transfer, which involves transferring healthy gut flora, further supports this link.
Building on these findings, the project investigated whether combining Clostridiales bacteria with bifidobacteria could further enhance their antitumor effects. Bifidobacteria are beneficial gut microbes known to promote intestinal balance and support the growth of other helpful bacteria. “We wanted to see whether this combination would amplify the antitumor activity of Clostridiales,” explains Scharl. Animal experiments confirmed this hypothesis: in mouse models of colorectal cancer, tumors grew more slowly, and increased numbers of immune cells infiltrated the tumor tissue when bifidobacteria were added.
“Our long-term goal is to use bacteria as a natural complement to cancer therapy,” says Scharl. In the future, such treatments might be administered as capsules or liquid formulations. This research offers new hope for cancer patients and highlights the vast therapeutic potential hidden within the complex world of gut microbes.
Your donations are making a lasting impact. Discover how Prof. Scharl and his research team are finding a new approach in cancer therapy, thanks to the support of generous donors like you.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser
